Progress of Federal Xarelto Lawsuits Pending in Multidistrict Litigation to Be Discussed During July 9th Status Conference
New York, New York (PRWEB) June 30, 2015 -- The progress of more than 500 Xarelto lawsuits (http://www.xareltolawsuit2015.com/) currently pending in a federal multidistrict litigation now underway in the U.S. District Court, Eastern District of Louisiana, will be addressed when the Court convenes its next monthly Status Conference. According to the Court’s calendar, that conference has now been scheduled for July 9th, at 9:00 a.m. (In Re: Xarelto Products Liability Litigation, No. 2592)
“Our Firm is representing Xarelto lawsuit plaintiffs in this proceeding, and we expect that this conference will address matters relevant to their claims. Those matters could include the selection of cases for bellwether trials, as the litigation is preparing to embark on that process. Issues affecting discovery and timetables for depositions are also likely to be discussed,” says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective medical devices and drugs. The Firm is actively filing Xarelto lawsuits in U.S. courts, and continues to evaluate claims on behalf of individuals who allegedly suffered life-threatening internal bleeding and other dangerous complications related to its use.
Xarelto Litigation
According to court documents, Xarelto is a new-generation anticoagulant that was approved by the U.S. Food & Drug Administration in 2011. Like other blood thinners, the medication can cause episodes of serious internal bleeding. However, unlike an older anticoagulant called warfarin, there is currently no approved antidote to reverse Xarelto bleeding. The drug’s label includes a black box warning that contains information about the increased risk of blood clot formation after premature discontinuation of the medication in the absence of adequate alternative anticoagulation.*
Court records indicate that at least 550 Xarelto lawsuits have been filed in the Eastern District of Louisiana, where federally-filed product liability claims involving the drug’s alleged association with uncontrollable internal bleeding and other complications have been consolidated for the purposes of pretrial proceedings. All of the lawsuits similarly allege that the manufacturers of Xarelto failed to provide patients and doctors with adequate warnings regarding its risks, and wrongly positioned the medication as a superior alternative to warfarin. Among other things, plaintiffs point out that internal bleeding associated with warfarin can be reversed via the administration of vitamin K.
Individuals who allegedly experienced serious complications related to Xarelto may be entitled to compensation for medical bills and other damages incurred as a result of their injuries. Learn more about filing a Xarelto lawsuit by visiting Bernstein Liebhard LLP’s website, or by calling 800-511-5092 to schedule a free, no obligation case review.
*accessdata.fda.gov/drugsatfda_docs/label/2013/022406s004lbl.pdf, FDA, March 2013
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The National Law Journal has recognized Bernstein Liebhard for twelve consecutive years as one of the top plaintiffs' firms in the country. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092
ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact Information:
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
info (at)consumerinjurylawyers(dot)com
http://www.xareltolawsuit2015.com/
https://plus.google.com/115936073311125306742?rel=author
Sandy A. Liebhard, Xarelto Lawsuit Claims Center, http://www.xareltolawsuit2015.com/, +1 800-511-5092, [email protected]
Share this article